(Q39529087)

12 September 2017

title

Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats (English)

1 reference

12 September 2017

0 references

J X Hao

1

1 reference

12 September 2017

X J Xu

series ordinal

2

1 reference

12 September 2017

L Urban

series ordinal

3

1 reference

12 September 2017

Z Wiesenfeld-Hallin

series ordinal

4

1 reference

12 September 2017

language of work or name

English

0 references

publication date

1 February 2000

1 reference

12 September 2017

1 reference

12 September 2017

volume

280

1 reference

12 September 2017

issue

3

1 reference

12 September 2017

page(s)

211-214

1 reference

Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Identification of novel ligands for the gabapentin binding site on the alpha2delta subunit of a calcium channel and their evaluation as anticonvulsant agents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Treatment of a chronic allodynia-like response in spinally injured rats: effects of systemically administered excitatory amino acid receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

The effect of gabapentin on neuropathic pain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin adjunctive therapy in neuropathic pain states

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin for the Treatment of Postherpetic Neuralgia: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

The antiepileptic agent gabapentin (Neurontin) possesses anxiolytic-like and antinociceptive actions that are reversed by D-serine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin, ineffective in normal rats, markedly reduces C-fibre evoked responses after inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin inhibits calcium currents in isolated rat brain neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

A summary of mechanistic hypotheses of gabapentin pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in plasma and brain microdialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2800%2900787-4

7 January 2021

10.1016/S0304-3940(00)00787-4

Identifiers

DOI

1 reference

12 September 2017

1 reference